Columns

Approaching an Unpredictable Life with Practicality

Editor’s Note: In his first post for Cystic Fibrosis News Today, Gunnar Esiason writes about his experiences in managing CF entirely on his own for the first time when he went away to college in 2009. Gunnar’s column explores the uncertainty that surrounds those with cystic fibrosis as they fight to live…

The Many Perspectives of the FDA Approval of ORKAMBI

On Thursday, July 2, the Food and Drug Administration made the announcement that Orkambi had been approved for people with cystic fibrosis who are age twelve and older with two copies of the F508del mutation. The announcement was followed by a swirling of excitement through the CF community and…

Cystic Fibrosis and the Bacteria Within

Cystic fibrosis is a complex genetic disease that slowly takes the breath of those who have it by eroding the function of their lungs over time. At the core of this erosion is a diverse community of bacteria competing to assert dominance in the lung, inflicting chronic exacerbations that need…

Endogenous Lung Stem Cells and Cystic Fibrosis, an Introduction

My past few articles have touched upon the application of stem cells for the treatment of cystic fibrosis (CF), and while some of these treatments demonstrate great promise for the future of CF, it is important to establish more necessary discourse. With my past articles discussing Embryonic Stem Cells (ESCs),…